Poly Medicure Limited has submitted a regulatory filing intimating the schedule of an investor meet pursuant to Regulation 30 and applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A.
The disclosure states that company officials will hold a one-on-one meeting with an analyst/investor. The details of the meeting are as follows:
- Investor: Axis Max Life
- Meeting Date: Wednesday, 23rd September 2026
- Time: 04:00 PM
- Format: One-on-one
The company has stated that the above schedule is subject to changes which may occur due to exigencies on the part of the analysts, investors, or the company. It is explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the meeting.
This information is also available on the company's website at www.polymedicure.com.
Financial Impact
No financial impact, operational details, or strategic updates are disclosed in this intimation. The filing is purely procedural to inform the exchanges of a scheduled investor interaction.